Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O75081
UPID:
MTG16_HUMAN
Alternative names:
MTG8-related protein 2; Myeloid translocation gene on chromosome 16 protein; Zinc finger MYND domain-containing protein 4
Alternative UPACC:
O75081; D3DX78; O60615; O60616; O60617; O75082; O75107; O75108; Q0P5Z6; Q6P5W6
Background:
Protein CBFA2T3, also known as MTG8-related protein 2, Myeloid translocation gene on chromosome 16 protein, and Zinc finger MYND domain-containing protein 4, plays a crucial role in cellular processes. It acts as a transcriptional corepressor, influencing gene expression by associating with DNA-binding transcription factors. This protein is involved in various cellular functions, including repression of MMP7 expression, regulation of HIF1A protein levels, and modulation of glycolysis and mitochondrial respiration. Additionally, it contributes to the differentiation of erythroid progenitors and granulocyte differentiation.
Therapeutic significance:
Understanding the role of Protein CBFA2T3 could open doors to potential therapeutic strategies. Its involvement in critical cellular processes such as glycolysis, mitochondrial respiration, and cell differentiation highlights its potential as a target for therapeutic intervention in diseases where these processes are dysregulated.